Your browser doesn't support javascript.
loading
Remarkable regression of inoperable pancreatic grade 3 neuroendocrine neoplasm after radioligand therapy with [177Lu]Lu-DOTATATE and [90Y]Y­DOTATATE.
Durma, Adam D; Saracyn, Marek; Kolodziej, Maciej; Józwik-Plebanek, Katarzyna; Kaminski, Grzegorz.
Afiliação
  • Durma AD; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine ­ National Research Institute, Warsaw, Poland. adurma@wim.mil.pl
  • Saracyn M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine ­ National Research Institute, Warsaw, Poland
  • Kolodziej M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine ­ National Research Institute, Warsaw, Poland
  • Józwik-Plebanek K; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine ­ National Research Institute, Warsaw, Poland
  • Kaminski G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine ­ National Research Institute, Warsaw, Poland
Pol Arch Intern Med ; 133(11)2023 11 29.
Article em En | MEDLINE | ID: mdl-37795839
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Radioisótopos de Ítrio Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Radioisótopos de Ítrio Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article